Cape Drugs Cited For Domperidone Compounding In FDA Warning Letter
This article was originally published in The Pink Sheet Daily
Domperidone-containing drugs are not recognized as safe and effective by qualified experts and are unapproved new drugs, the warning letter says.
You may also be interested in...
The citations are part of warning letters issued for compounding of domperidone, a lactation product which is not approved by FDA. The agency issues a Talk Paper that warns breastfeeding women about the safety risks of domperidone.
The dual GLP-1/GIP agonist outpaced Novo's blockbuster GLP-1 analogue at all three doses, including the important low dose, on A1C reduction and weight reduction in patients with type 2 diabetes.
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.